Emirates Drug Establishment Approves Lipfendra for High Cholesterol
The Emirates Drug Establishment approved Lipfendra for adults with elevated low-density lipoprotein cholesterol, making the United Arab Emirates the second country worldwide to authorize the treatment, according to a press release issued by the regulatory body. Taken orally once daily, the medication targets LDL-C, which remains one of the primary risk factors for cardiovascular disease. … Read more